Gender Selection IVF with PGT in Cyprus – Familiy Balancing
What Is Gender Selection in IVF?
Gender Selection in Cyprus is an advanced IVF treatment that allows intended parents to determine the gender of their baby before embryo transfer using PGD / NGS. During IVF treatment, embryos are created in a laboratory environment and genetically analyzed to identify whether they are male or female.
During IVF treatment, embryos are created in the laboratory by fertilizing the egg with sperm. A small cell sample is then taken from the embryo and analyzed through PGT / PGD genetic testing.
This analysis evaluates the chromosomal structure of the embryo, allowing specialists to identify whether the embryo is male or female.
Embryos that meet both genetic health criteria and the family’s gender preference can then be selected for embryo transfer.
Is Gender Selection Possible in IVF?
Yes. Gender Selection treatments allow the gender of embryos to be determined through Preimplantation Genetic Testing (PGT) for family planning and medical reasons.
During IVF treatment:
- Eggs are fertilized with sperm in the laboratory
- Embryos are developed under controlled laboratory conditions
- A cell biopsy is taken from the embryo
- The embryo is analyzed for genetic abnormalities and gender
Based on the genetic analysis results, embryos identified as male or female can be selected for transfer according to the parents’ preferences.
Gender Selection IVF / Sex Selection IVF – Why Choose Cyprus?
Gender Selection in Cyprus is widely preferred by international patients due to advanced IVF laboratories and experienced fertility specialists.
Gender determination is performed through PGT genetic testing, which provides accurate results regarding the embryo’s chromosomal structure.
Important points about Gender Selection Treatment in Cyprus:
- Gender selection is only possible through IVF treatment
- The procedure is performed using Preimplantation Genetic Testing (PGT)
- Natural pregnancy methods cannot determine gender medically
- Non-medical gender prediction methods have no scientific reliability
For this reason, PGT-based gender selection remains the only medically reliable method.
What Is Preimplantation Genetic Testing (PGT)?
Preimplantation Genetic Testing (PGT) is a genetic screening technique used during IVF treatment.
The primary purpose of PGT is to:
- Detect genetic diseases
- Identify chromosomal abnormalities
- Determine embryo gender
During the procedure:
- A small cell sample is taken from the embryo.
- The sample is analyzed in a genetic laboratory.
- Chromosomal abnormalities and gender are identified.
Embryos that show healthy genetic results are selected for embryo transfer.
When Is Gender Selection IVF with PGT Recommended?
Gender Selection treatment in Cyprus using PGT may be recommended in several situations:
- Presence of gender-linked genetic diseases
- Risk of inherited chromosomal abnormalities
- Recurrent miscarriages
- Consanguineous marriage
- Previous child affected by a genetic disease
- Women aged over 40
- Repeated IVF failure
- Family Balancing
In such cases, PGT testing can help identify genetically healthy embryos before transfer.
Required Tests Before Gender Selection Treatment in Cyprus
Patients planning Gender Selection treatment in Cyprus must complete certain medical tests before starting the procedure.
Tests for the Female Partner
- FSH
- LH
- Estradiol (E2)
- AMH
- Prolactin (PRL)
- TSH, T3, T4
- Fasting blood glucose
- Complete blood count
- HBsAg, Anti-HCV, HIV, VDRL
Imaging tests may include:
- Pelvic ultrasound
- Hysterosalpingography (HSG)
Tests for the Male Partner
- Semen analysis
- HBsAg, Anti-HCV, HIV, VDRL
- FSH and LH hormone levels
These tests help determine whether the couple is suitable for gender selection IVF treatment.
Stages of Gender Selection Treatment in Cyprus
To undergo Gender Selection, patients must first begin IVF treatment.
The treatment stages include:
- Ovarian stimulation to produce multiple eggs
- Egg retrieval procedure
- Fertilization of eggs with sperm in the laboratory
- Embryo development in specialized incubators
- Embryo biopsy for PGT testing
- Genetic analysis to determine embryo gender
- Selection of healthy embryos for transfer
Embryos matching the family’s gender preference and genetic health criteria are transferred into the uterus.
After Gender Selection Treatment
After embryo transfer, the post-treatment waiting period begins.
Patients typically wait about 12 days before performing a pregnancy blood test (β-hCG).
- If the result is negative, medications are discontinued.
- If the result is positive, the pregnancy follow-up process begins.
Pregnancies achieved through Gender Selection IVF treatment are monitored similarly to other IVF pregnancies.
Gender Selection Treatment Success Rates in Cyprus
The success of Gender Selection Treatment depends on several factors:
- Age of the female partner
- Egg quantity and quality
- Embryo quality
- Laboratory technology
Patients under 35 years old generally experience higher success rates due to better egg quality.
For patients with low egg numbers, specialists may recommend Embryo Pooling to increase the number of embryos available for testing.
For women over 45 years old, options such as egg donation or Tandem IVF may be considered.
Why Choose Our Center for Gender Selection?
At our Cyprus IVF Center, gender selection procedures are performed using advanced genetic technologies.
Our center offers:
- In-house genetic laboratory
- NGS (Next Generation Sequencing) testing
- Comprehensive 24 chromosome screening
- Microsort sperm separation technology
- Advanced embryology laboratory infrastructure
Advantages of Our Sex Selection IVF Treatment Program
- High success rates
- Experienced fertility specialists
- Advanced laboratory technology
- Personalized treatment planning
- International patient care experience
Our goal is to provide safe and effective Gender Selection treatment in Cyprus using the most advanced reproductive technologies available.
